CAR T-cell

Chimeric antigen receptor (CAR) T-cell therapy represents a revolutionary improvement in customized cancer treatment. CAR T-cells are made by collecting T cells from the patient and engineered in the laboratory to be commensurate with chimeric antigen receptors.  

The strategy of CAR T-cell

CAR T-cells are modulated receptors that consist of four main components; antigen binding domain, hinge region, transmembrane domain, and intracellular signaling domains